Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-008857
Filing Date
2025-03-14
Accepted
2025-03-14 17:22:25
Documents
7
Period of Report
2025-03-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20044910x1_pre14a.htm PRE 14A 373073
2 logo_plustherapeutics1.jpg GRAPHIC 33360
3 ny20044910x1_internet.jpg GRAPHIC 5735
4 ny20044910x1_mail.jpg GRAPHIC 6660
5 ny20044910x1_pc01.jpg GRAPHIC 793450
6 ny20044910x1_pc02.jpg GRAPHIC 648527
7 ny20044910x1_phone.jpg GRAPHIC 6434
  Complete submission text file 0001140361-25-008857.txt   2430928
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34375 | Film No.: 25741362
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)